{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:23:09Z","timestamp":1774084989569,"version":"3.50.1"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ejmech.2024.116532","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T23:49:57Z","timestamp":1716508197000},"page":"116532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Recent advances in targeting histone H3 lysine 36 methyltransferases for cancer therapy"],"prefix":"10.1016","volume":"274","author":[{"given":"Sai","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanlu","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangkui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-0122","authenticated-orcid":false,"given":"Qidong","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7558-5504","authenticated-orcid":false,"given":"Xiaoke","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejmech.2024.116532_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nsmb.2123","article-title":"Splicing enhances recruitment of methyltransferase HYPB\/Setd2 and methylation of histone H3 Lys36","volume":"18","author":"de Almeida","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5968","key":"10.1016\/j.ejmech.2024.116532_bib2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.1184208","article-title":"Regulation of alternative splicing by histone modifications","volume":"327","author":"Luco","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116532_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.bi.44.070175.002251","article-title":"Biological methylation: selected aspects","volume":"44","author":"Cantoni","year":"1975","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrm3274","article-title":"Understanding the language of Lys36 methylation at histone H3","volume":"13","author":"Wagner","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116532_bib5","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/MCB.22.5.1298-1306.2002","article-title":"Set2 is a nucleosomal histone H3-selective methyltransferase that mediates transcriptional repression","volume":"22","author":"Strahl","year":"2002","journal-title":"Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116532_bib6","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1074\/jbc.M110.204115","article-title":"The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation","volume":"286","author":"Qiao","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116532_bib7","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/2159-8290.CD-18-0083","article-title":"PTEN methylation by NSD2 controls cellular sensitivity to DNA damage","volume":"9","author":"Zhang","year":"2019","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116532_bib8","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026708","article-title":"The role of nuclear receptor-binding SET domain family histone lysine methyltransferases in cancer","volume":"7","author":"Bennett","year":"2017","journal-title":"Cold Spring Harbor Perspec. Med."},{"key":"10.1016\/j.ejmech.2024.116532_bib9","article-title":"The histone methyltransferase Ash1l is required for epidermal homeostasis in mice","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s13039-020-00483-5","article-title":"A chromosome 1q22 microdeletion including ASH1L is associated with intellectual disability in a Chinese family","volume":"13","author":"Xi","year":"2020","journal-title":"Mol. Cytogenet."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib11","article-title":"SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.ejmech.2024.116532_bib12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3324\/haematol.2018.187708","article-title":"Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation","volume":"103","author":"Zhou","year":"2018","journal-title":"Haematologica"},{"issue":"23","key":"10.1016\/j.ejmech.2024.116532_bib13","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1038\/onc.2012.297","article-title":"The histone methyltransferase MMSET\/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer","volume":"32","author":"Ezponda","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ejmech.2024.116532_bib14","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1182\/blood-2007-06-092122","article-title":"The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor","volume":"111","author":"Marango","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbcan.2011.05.004","article-title":"Cancers and the NSD family of histone lysine methyltransferases","volume":"1816","author":"Morishita","year":"2011","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116532_bib16","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.bbagen.2015.05.013","article-title":"Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2","volume":"1850","author":"Eram","year":"2015","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molcel.2012.07.020","article-title":"Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20","volume":"48","author":"Stender","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2024.116532_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13072-017-0115-7","article-title":"SMYD5 regulates H4K20me3-marked heterochromatin to safeguard ES cell self-renewal and prevent spurious differentiation","volume":"10","author":"Kidder","year":"2017","journal-title":"Epigenet. Chromatin"},{"issue":"23","key":"10.1016\/j.ejmech.2024.116532_bib19","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1158\/0008-5472.CAN-17-0828","article-title":"SMYD5 controls heterochromatin and chromosome integrity during embryonic stem cell differentiation","volume":"77","author":"Kidder","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-020-00243-y","article-title":"Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia","volume":"8","author":"Sun","year":"2020","journal-title":"Biomark. Res."},{"issue":"25","key":"10.1016\/j.ejmech.2024.116532_bib21","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood.2019001963","article-title":"SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS","volume":"135","author":"Chen","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2024.116532_bib22","article-title":"SET domain containing 2 deficiency in myelodysplastic syndrome","volume":"11","author":"Li","year":"2020","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib23","first-page":"773","article-title":"Ukccg, A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia","volume":"94","author":"Jaju","year":"1999","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116532_bib24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood.V98.4.1264","article-title":"A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia","volume":"98","author":"Jaju","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ejmech.2024.116532_bib25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ncb1608","article-title":"NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis","volume":"9","author":"Wang","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116532_bib26","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V99.10.3857","article-title":"NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)","volume":"99","author":"Rosati","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejmech.2024.116532_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.molcel.2015.10.033","article-title":"NSD3-Short is an adaptor protein that couples BRD4 to the CHD8 chromatin remodeler","volume":"60","author":"Shen","year":"2015","journal-title":"Mol. Cell"},{"issue":"22","key":"10.1016\/j.ejmech.2024.116532_bib28","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.2718.2718","article-title":"MIR142 loss-of-function mutations promote leukemogenesis through derepression of ASH1L resulting in increased HOX gene expression","volume":"128","author":"Yao","year":"2016","journal-title":"Blood"},{"issue":"7846","key":"10.1016\/j.ejmech.2024.116532_bib29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-020-03170-y","article-title":"Elevated NSD3 histone methylation activity drives squamous cell lung cancer","volume":"590","author":"Yuan","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41388-018-0429-3","article-title":"Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer","volume":"38","author":"Kim","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116532_bib31","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/cas.15299","article-title":"Methyltransferase SETD2 inhibits tumor growth and metastasis via STAT1-IL-8 signaling-mediated epithelial-mesenchymal transition in lung adenocarcinoma","volume":"113","author":"Yang","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejmech.2024.116532_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep32952","article-title":"NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation","volume":"6","author":"Garcia-Carpizo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116532_bib33","article-title":"The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies","volume":"8","author":"Li","year":"2017","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.ejmech.2024.116532_bib34","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2017-03-775569","article-title":"SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia","volume":"130","author":"Mar","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ejmech.2024.116532_bib35","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/ng.2777","article-title":"Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia","volume":"45","author":"Jaffe","year":"2013","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1158\/2159-8290.CD-20-1771","article-title":"PRC2 inhibitors overcome glucocorticoid resistance driven by NSD2 mutation in pediatric acute lymphoblastic leukemia","volume":"12","author":"Li","year":"2022","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/1541-7786.MCR-14-0292-T","article-title":"WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck","volume":"13","author":"Saloura","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116532_bib38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116532_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108769","article-title":"Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma","volume":"34","author":"Farhangdoost","year":"2021","journal-title":"Cell Rep."},{"issue":"27","key":"10.1016\/j.ejmech.2024.116532_bib40","doi-asserted-by":"crossref","first-page":"42527","DOI":"10.18632\/oncotarget.9897","article-title":"WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck","volume":"7","author":"Saloura","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116532_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/srep40664","article-title":"WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer","volume":"7","author":"Saloura","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116532_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01877-7","article-title":"NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis","volume":"8","author":"Peri","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-01842-6","article-title":"NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma","volume":"10","author":"Topchu","year":"2024","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116532_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16061180","article-title":"PIP4K2B protein regulation by NSD1 in HPV-negative head and neck squamous cell carcinoma","volume":"16","author":"Topchu","year":"2024","journal-title":"Cancers"},{"issue":"Supplement 1","key":"10.1016\/j.ejmech.2024.116532_bib45","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood-2021-145120","article-title":"H3K36 trimethylation mediated by SETD2 regulates cell proliferation and cell cycle by modulating BCMA-JNK and c-myc pathways in multiple myeloma","volume":"138","author":"Zhou","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116532_bib46","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1158\/0008-5472.CAN-20-2946","article-title":"SMARCA2 is a novel interactor of NSD2 and regulates prometastatic PTP4A3 through chromatin remodeling in t(4;14) multiple myeloma","volume":"81","author":"Chong","year":"2021","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.ejmech.2024.116532_bib47","article-title":"The predictive values of loss-of-function variants in histone methyltransferases for response to immune checkpoint inhibitors in solid tumors","volume":"39","author":"Liang","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"29","key":"10.1016\/j.ejmech.2024.116532_bib48","doi-asserted-by":"crossref","first-page":"27847","DOI":"10.18632\/oncotarget.4443","article-title":"LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2024.116532_bib49","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2741\/4834","article-title":"SETD2, an epigenetic tumor suppressor: a focused review on GI tumor","volume":"25","author":"Hu","year":"2020","journal-title":"Front. Biosci. Landmark"},{"key":"10.1016\/j.ejmech.2024.116532_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/srep07336","article-title":"Mutations of epigenetic regulatory genes are common in thymic carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116532_bib51","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1158\/1078-0432.CCR-21-3581","article-title":"Molecular characterization of KRAS wild-type tumors in patients with pancreatic adenocarcinoma","volume":"28","author":"Philip","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.116532_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102004","article-title":"The histone methyltransferase SETD2 modulates oxidative stress to attenuate experimental colitis","volume":"43","author":"Liu","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2024.116532_bib53","first-page":"193","article-title":"Integrated analysis of genetic abnormalities of the histone lysine methyltransferases in prostate cancer","volume":"25","author":"Zhang","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.ejmech.2024.116532_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07511-4","article-title":"NSD2 is a conserved driver of metastatic prostate cancer progression","volume":"9","author":"Aytes","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116532_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105888","article-title":"Role of NSD1 as potential therapeutic target in tumor","volume":"173","author":"Yang","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116532_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04205-6","article-title":"Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116532_bib57","first-page":"3513","article-title":"NSD2 is downregulated in T2DM and promotes beta cell proliferation and insulin secretion through the transcriptionally regulation of PDX1","volume":"18","author":"Shi","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2024.116532_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00435","article-title":"Somatic mutations profile of a young patient with metastatic urothelial carcinoma reveals mutations in genes involved in ion channels","volume":"9","author":"Sharma","year":"2019","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116532_bib59","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1593\/neo.11048","article-title":"Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway","volume":"13","author":"Toyokawa","year":"2011","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/gcc.22012","article-title":"The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis","volume":"52","author":"Kang","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.ejmech.2024.116532_bib61","first-page":"928","article-title":"NSD2 promotes osteosarcoma cell proliferation and metastasis by inhibiting E-cadherin expression","volume":"21","author":"Lu","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.116532_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1347-1","article-title":"Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma","volume":"10","author":"He","year":"2019","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116532_bib63","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.3892\/or.2017.5936","article-title":"Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis","volume":"38","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116532_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030699","article-title":"Potential involvement of NSD1, KRT24 and ACACA in the genetic predisposition to colorectal cancer","volume":"14","author":"Quintana","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ejmech.2024.116532_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04267-6","article-title":"Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2024.116532_bib66","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.2147\/OTT.S191732","article-title":"Downregulation of NSD3 (WHSC1L1) inhibits cell proliferation and migration via ERK 1\/2 deactivation and decreasing CAPG expression in colorectal cancer cells","volume":"12","author":"Yi","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116532_bib67","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","article-title":"NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism","volume":"4","author":"French","year":"2014","journal-title":"Cancer Discov."},{"issue":"18","key":"10.1016\/j.ejmech.2024.116532_bib68","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1158\/0008-5472.CAN-17-0143","article-title":"NSD1 inactivation and SETD2 mutation drive a convergence toward loss of function of H3K36 writers in clear cell renal cell carcinomas","volume":"77","author":"Su","year":"2017","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116532_bib69","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.7150\/ijms.36128","article-title":"Knockdown of NSD2 suppresses renal cell carcinoma metastasis by inhibiting epithelial-mesenchymal transition","volume":"16","author":"Han","year":"2019","journal-title":"Int. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116532_bib70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bbrc.2019.08.020","article-title":"NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-beta\/TGF-beta RI\/SMADs signaling","volume":"519","author":"Zhu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib71","first-page":"301","article-title":"Amplification of the NSD3-BRD4-CHD8 pathway in pelvic high-grade serous carcinomas of tubo-ovarian and endometrial origin","volume":"7","author":"Jones","year":"2017","journal-title":"Mol. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.ejmech.2024.116532_bib72","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1074\/jbc.RA120.013530","article-title":"Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma","volume":"295","author":"Xu","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116532_bib73","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41594-019-0298-7","article-title":"Histone lysine methyltransferases in biology and disease","volume":"26","author":"Husmann","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116532_bib74","first-page":"2219","article-title":"Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer","volume":"18","author":"Meng","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2024.116532_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-018-0623-0","article-title":"SETD2 mutations in primary central nervous system tumors","volume":"6","author":"Viaene","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116532_bib76","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cell.2013.03.025","article-title":"The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutS alpha","volume":"153","author":"Li","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ejmech.2024.116532_bib77","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cellsig.2008.05.012","article-title":"Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes","volume":"20","author":"Xie","year":"2008","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116532_bib78","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijrobp.2022.02.018","article-title":"SETD2 palmitoylation mediated by ZDHHC16 in epidermal growth factor receptor-mutated glioblastoma promotes ionizing radiation-induced DNA damage","volume":"113","author":"Fan","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"41","key":"10.1016\/j.ejmech.2024.116532_bib79","doi-asserted-by":"crossref","first-page":"43452","DOI":"10.18632\/oncotarget.6171","article-title":"Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing","volume":"6","author":"Patil","year":"2015","journal-title":"Oncotarget"},{"issue":"51","key":"10.1016\/j.ejmech.2024.116532_bib80","doi-asserted-by":"crossref","first-page":"21830","DOI":"10.1073\/pnas.0906831106","article-title":"Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma","volume":"106","author":"Berdasco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116532_bib81","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/neuonc\/noz175.409","article-title":"Influence of epigenetic modulation of the t-cell regulators expression on glioblastomas by histone 3 lysine methyltransferase or demethylase on the prognosis of the glioblastoma patients","volume":"21","author":"Kim","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2024.116532_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-9-290","article-title":"The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters","volume":"9","author":"Al Sarakbi","year":"2009","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib83","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1080\/21655979.2021.2018973","article-title":"Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt\/beta-catenin signaling pathway","volume":"13","author":"Chen","year":"2022","journal-title":"Bioengineered"},{"issue":"7","key":"10.1016\/j.ejmech.2024.116532_bib84","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/cr.2014.71","article-title":"An epigenomic approach to therapy for tamoxifen-resistant breast cancer","volume":"24","author":"Feng","year":"2014","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116532_bib85","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41401-018-0199-z","article-title":"Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling","volume":"40","author":"Wang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.116532_bib86","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2147\/OTT.S196430","article-title":"Downregulation of MMSET impairs breast cancer proliferation and metastasis through inhibiting Wnt\/beta-catenin signaling","volume":"12","author":"Zhao","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"21","key":"10.1016\/j.ejmech.2024.116532_bib87","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1158\/0008-5472.CAN-10-1013","article-title":"Transforming properties of 8p11-12 amplified genes in human breast cancer","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib88","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/0008-5472.CAN-20-0360","article-title":"NSD3-Induced methylation of H3K36 activates NOTCH signaling to drive breast tumor initiation and metastatic progression","volume":"81","author":"Jeong","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116532_bib89","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.18632\/oncotarget.2967","article-title":"Genetic alterations of histone lysine methyltransferases and their significance in breast cancer","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejmech.2024.116532_bib90","first-page":"3851","article-title":"Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis","volume":"17","author":"Song","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26913-5","article-title":"Structural basis of the regulation of the normal and oncogenic methylation of nucleosomal histone H3 Lys36 by NSD2","volume":"12","author":"Sato","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib92","article-title":"Sequence specificity analysis of the SETD2 protein lysine methyltransferase and discovery of a SETD2 super-substrate","volume":"3","author":"Schuhmacher","year":"2020","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib93","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.emboj.7601967","article-title":"Dynamic histone H3 methylation during gene induction: HYPB\/Setd2 mediates all H3K36 trimethylation","volume":"27","author":"Edmunds","year":"2008","journal-title":"EMBO J."},{"issue":"7846","key":"10.1016\/j.ejmech.2024.116532_bib94","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-020-03069-8","article-title":"Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases","volume":"590","author":"Li","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ejmech.2024.116532_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060783","article-title":"Unique SMYD5 structure revealed by AlphaFold correlates with its functional divergence","volume":"12","author":"Zhang","year":"2022","journal-title":"Biomolecules"},{"issue":"14","key":"10.1016\/j.ejmech.2024.116532_bib96","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1101\/gad.284323.116","article-title":"Molecular basis for oncohistone 113 recognition by SETD2 methyltransferase","volume":"30","author":"Yang","year":"2016","journal-title":"Genes Dev."},{"issue":"39","key":"10.1016\/j.ejmech.2024.116532_bib97","doi-asserted-by":"crossref","first-page":"16952","DOI":"10.1073\/pnas.1002653107","article-title":"Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function","volume":"107","author":"Lucio-Eterovic","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116532_bib98","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/epi.15.32","article-title":"The NSD family of protein methyltransferases in human cancer","volume":"7","author":"Vougiouklakis","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.ejmech.2024.116532_bib99","article-title":"RE-IIBP methylates H3K79 and induces MEIS1-mediated apoptosis via H2BK120 ubiquitination by RNF20","volume":"5","author":"Park","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116532_bib100","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1021\/acschembio.6b00308","article-title":"Structure of the epigenetic oncogene MMSET and inhibition by N-alkyl Sinefungin derivatives","volume":"11","author":"Tisi","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib101","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/geno.2001.6524","article-title":"NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines","volume":"74","author":"Angrand","year":"2001","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib102","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbrc.2006.04.095","article-title":"Characterization of a novel WHSC1-associated SET domain protein with H3K4 and H3K27 methyltransferase activity","volume":"345","author":"Kim","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116532_bib103","doi-asserted-by":"crossref","first-page":"8369","DOI":"10.1074\/jbc.M110.203380","article-title":"Crystal structure of the human histone methyltransferase ASH1L catalytic domain and its implications for the regulatory mechanism","volume":"286","author":"An","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"6340","key":"10.1016\/j.ejmech.2024.116532_bib104","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3321","article-title":"A subcellular map of the human proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116532_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2021.02.073","article-title":"Sperm chromatin-condensing protamine enhances SMYD5 thermal stability","volume":"550","author":"Zhang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2024.116532_bib106","doi-asserted-by":"crossref","DOI":"10.1161\/res.129.suppl_1.P499","article-title":"Histone H4K20 trimethylation is differentially regulated in heart disease","volume":"129","author":"Hickenlooper","year":"2021","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116532_bib107","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1021\/acsmedchemlett.1c00272","article-title":"Discovery of a first-in-class inhibitor of the histone methyltransferase SETD2 suitable for preclinical studies","volume":"12","author":"Lampe","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116532_bib108","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.2c00167","article-title":"Conformational-design-driven discovery of EZM0414: a selective, potent SETD2 inhibitor for clinical studies","author":"Alford","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"issue":"35","key":"10.1016\/j.ejmech.2024.116532_bib109","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1074\/jbc.RA118.004274","article-title":"High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2","volume":"293","author":"Coussens","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib110","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1021\/acs.jmedchem.2c01920","article-title":"Structural modification and pharmacological evaluation of substituted quinoline-5,8-diones as potent NSD2 inhibitors","volume":"66","author":"Tang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116532_bib111","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41589-020-0626-6","article-title":"Covalent inhibition of NSD1 histone methyltransferase","volume":"16","author":"Huang","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116532_bib112","doi-asserted-by":"crossref","first-page":"113","DOI":"10.15430\/JCP.2015.20.2.113","article-title":"Inhibition of nuclear receptor binding SET domain 2\/multiple myeloma SET domain by LEM-06 implication for epigenetic cancer therapies","volume":"20","author":"di Luccio","year":"2015","journal-title":"J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib113","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbrc.2018.11.037","article-title":"Identification of LEM-14 inhibitor of the oncoprotein NSD2","volume":"508","author":"Shen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.ejmech.2024.116532_bib114","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/j.bmcl.2018.08.012","article-title":"Novel inhibitors of As(III) S-adenosylmethionine methyltransferase (AS3MT) identified by virtual screening","volume":"28","author":"Burli","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2024.116532_bib115","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/acs.jmedchem.0c01768","article-title":"Discovery of small-molecule antagonists of the PWWP domain of NSD2","volume":"64","author":"de Freitas","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116532_bib116","volume":"vol. 2021","author":"Dilworth","year":"2021"},{"issue":"15","key":"10.1016\/j.ejmech.2024.116532_bib117","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1021\/acs.jmedchem.2c00807","article-title":"Discovery of a first-in-class degrader for nuclear receptor binding SET domain protein 2 (NSD2) and ikaros\/aiolos published as part of the journal of medicinal chemistry special issue \"epigenetics 2022\"","volume":"65","author":"Meng","year":"2022","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2024.116532_bib118","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1021\/jacs.3c01421","article-title":"Discovery of a potent and selective targeted NSD2 degrader for the reduction of H3K36me2","volume":"145","author":"Hanley","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116532_bib119","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41589-019-0310-x","article-title":"Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3","volume":"15","author":"Boettcher","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116532_bib120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.chembiol.2021.08.004","article-title":"A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells","volume":"29","author":"Xu","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.116532_bib121","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2023-174550","article-title":"Trial in progress: a phase 1 study of KTX-1001, an oral, first-in-class, selective MMSET inhibitor in patients with relapsed and refractory multiple myeloma","volume":"142","author":"Berdeja","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116532_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23152-6","article-title":"Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity","volume":"12","author":"Rogawski","year":"2021","journal-title":"Nat. Commun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424004124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:22:50Z","timestamp":1719310970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424004124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":122,"alternative-id":["S0223523424004124"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116532","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in targeting histone H3 lysine 36 methyltransferases for cancer therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116532"}}